Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 410 of 1,261

  1. US 10722550

    Compositions and methods for the treatment of fungal infections

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  2. US 10722540

    Microfluidic device and method for shear stress-induced transformation of cells

    The Regents of the University of California · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  3. US 10722537

    Activation of resident memory T cells for cancer immunotherapy

    Regents of the University of Minnesota · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  4. US 10722525

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  5. US 10722504

    4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  6. US 10722487

    Glutaminase inhibitor therapy

    The Board of Regents of the University of Texas System · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  7. US 10722459

    Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses

    United Kingdom Research and Innovation · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  8. US 10723764

    Anti-microbial peptides and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  9. US 10724020

    Compositions for linking DNA-binding domains and cleavage domains

    Sangamo Therapeutics, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  10. US 10717981

    Therapeutic compositions and methods of making and using the same

    Advanced ReGen Medical Technologies, LLC · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  11. US 10717765

    Compositions and methods for treating autoimmune and inflammatory disorders

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  12. US 10717764

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  13. US 10717993

    Methods and compositions for increased transgene expression

    Sangamo Therapeutics, Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  14. US 10717748

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  15. US 10717732

    Inhibitors of influenza virus replication, application methods and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  16. US 10716860

    Cochleates made with soy phosphatidylserine

    MATINAS BIOPHARMA NANOTECHNOLOGIES, INC. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  17. US 10716856

    Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

    The Board of Regents of the University of Texas System · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  18. US 10716854

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  19. US 10716851

    Agonist antibodies that bind human CD137 and uses thereof

    Compass Therapeutics LLC · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  20. US 10716843

    Immune enhancing recombinant dengue protein

    United States of America as represented by the Secretary of the Air Force · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  21. US 10716853

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  22. US 10716852

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  23. US 10717720

    Modified compound of andrographolide

    Medshine Discovery Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  24. US 10716808

    Methods and compositions to modulate hair growth

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.